What is the ROCE (Return on Capital Employed) of Aptinyx this year?
The ROCE of Aptinyx is -1.63 undefined this year.
Aptinyx ROCE 2024
Aptinyx ROCE
-1.63
Ticker
APTX
ISIN
US03836N1037
WKN
A2JPB1
In 2024, Aptinyx's return on capital employed (ROCE) was -1.63, a 107.58% increase from the -0.79 ROCE in the previous year.
Aptinyx Aktienanalyse
What does Aptinyx do?
Aptinyx Inc is a biopharmaceutical company specializing in the development of therapies for the treatment of neurological diseases. The company was founded in 2015 in Evanston, Illinois, USA, and has since achieved an impressive track record in researching and developing innovative therapies. The history of Aptinyx Inc begins with a group of experienced scientists and researchers who came together to push the boundaries of neuroscience research and discover new treatment options for people with brain disorders. The company is based on the belief that the human brain is a fascinating and complex entity that still holds many secrets. The company is committed to improving human well-being through innovative neurotherapeutic products and services. Aptinyx Inc's business model focuses on the research, development, and commercialization of novel therapeutic treatments for neurological diseases. The company closely collaborates with leading academic institutions and facilities to leverage the best research findings and methods. The company has a strong scientific foundation led by an experienced team of researchers and developers working on innovative biomarker and therapy strategies. Aptinyx Inc has focused on the development of neuromodulators and neuroprotectants to treat neurological diseases, including pain disorders, peripheral neuropathies, neuropathic pain, Parkinson's disease, post-traumatic stress disorder (PTSD), and other central nervous system disorders. Aptinyx Inc's products are based on a comprehensive understanding of the fundamentals of the nervous system and how it functions. The company offers a variety of products and services, including novel therapeutics for the treatment of pain, neuropathy, and other neurological diseases. These products are based on the utilization of Aptinyx's proprietary technologies to selectively modulate specific cell types and signaling pathways in the nervous system. The products and services of Aptinyx Inc have been regulated by leading health authorities in the US and Europe. Aptinyx Inc has two main divisions of products: the first focus is on the development of neuromodulators that specifically alleviate pain and modulate the brain. The second focus is on the development of neuroprotectants that help protect neurons and reduce inflammation in the nervous system. These two divisions are closely interconnected as they are based on a common platform grounded in the exploration of novel biomarkers and therapeutic targets. The products of Aptinyx Inc are designed for both pain relief and improvement of neural functions. Additionally, these products aim to enhance patient experience and quality of life. The company consistently collaborates with potential partners and experts to develop products tailored to the needs of patients and healthcare providers. Overall, Aptinyx Inc has revolutionized the world of neuroscience by exploring and developing innovative solutions for neurological diseases. The company has achieved an impressive track record by utilizing its scientific expertise and groundbreaking technologies to set new trends in neuroscience research and therapeutics. In summary, Aptinyx Inc has developed a unique approach to the development of neuromodulators and neuroprotectants based on a deep understanding of the structure and function of the nervous system. The products and services of the company have the potential to play a significant role in improving the quality of life for patients with neurological diseases. Aptinyx ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Aptinyx's Return on Capital Employed (ROCE)
Aptinyx's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Aptinyx's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Aptinyx's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Aptinyx’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Aptinyx stock
How has the ROCE (Return on Capital Employed) of Aptinyx developed compared to the previous year?
The ROCE of Aptinyx has increased by 107.58% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Aptinyx?
A high Return on Capital Employed (ROCE) indicates that Aptinyx has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Aptinyx?
A low ROCE (Return on Capital Employed) can indicate that Aptinyx has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Aptinyx impact the company?
An increase in the ROCE of Aptinyx can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Aptinyx affect the company?
A decrease in ROCE of Aptinyx can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Aptinyx?
Some factors that can affect Aptinyx's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Aptinyx so important for investors?
The ROCE of Aptinyx is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Aptinyx take to improve the ROCE?
To improve the ROCE, Aptinyx can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Aptinyx pay?
Over the past 12 months, Aptinyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aptinyx is expected to pay a dividend of 0 USD.
What is the dividend yield of Aptinyx?
The current dividend yield of Aptinyx is .
When does Aptinyx pay dividends?
Aptinyx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Aptinyx?
Aptinyx paid dividends every year for the past 0 years.
What is the dividend of Aptinyx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Aptinyx located?
Aptinyx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Aptinyx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Aptinyx from 12/29/2023 amounting to 0.099 USD, you needed to have the stock in your portfolio before the ex-date on 1/2/2024.
When did Aptinyx pay the last dividend?
The last dividend was paid out on 12/29/2023.
What was the dividend of Aptinyx in the year 2023?
In the year 2023, Aptinyx distributed 0 USD as dividends.
In which currency does Aptinyx pay out the dividend?
The dividends of Aptinyx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Aptinyx
Our stock analysis for Aptinyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aptinyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
